March 31, 2020

Infection Surveillance Solutions Market will be growing at a CAGR of 12.4% during the forecast period from 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Infection Surveillance Solutions Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global market for infection surveillance solutions is set to grow from US$ 330.7 million in 2017 to US$ 934.7 million in 2026 with a CAGR increase of 12.4 per cent from 2018 to 2026.

Market Insights 

Lack of sanitation, non-compliance with prescribed medications and an increasing trend in self-medication have resulted in resistance to antibiotics by bacteria. There is an urgent need for a surveillance system to keep abreast of the spread of hospital-acquired infections and the mortality associated with terrible diseases such as pneumonia, tuberculosis, ebola, malaria, etc. Rising public health awareness and proactive government policies to curb the deleterious impact of infectious diseases are driving infection surveillance solutions to market growth.

Browse Full Report Originally Published by Credence Research at

Software solutions are generating huge growth in the market for infection surveillance solutions in the product segment. The ability to monitor infectious diseases in primary health centers and rampant growth in the global IT-health sector drives market growth in software solutions. Services are growing at a steady pace due to the entry of numerous market participants providing outsourcing solutions for infection surveillance.

Urinary tract infection is a leading segment of the market for infection surveillance solutions. Prolonged use of catheter and an increasing number of immunocompromised patients are leading to urinary tract infection. Other infections such as MRSA and pneumonia will have an impressive increase due to increased antibiotic resistance and a lack of treatment regimen to counteract its deleterious effect.

Hospitals currently dominate the end-use segment of the market for infection surveillance solutions. A significant increase in the number of surgeries performed and an increasing number of inbound patients are driving the growth of the hospital market. Long-term care centers will increase at a faster pace due to their ability to treat patients with microorganism resistance to antibiotics and increasing outgoing patients due to low healthcare costs.

North America is a clear leader in the regional segment of infection surveillance solutions with a market share of 35%. Growing cases of hospital-acquired infections and the existence of a well-developed health care framework are the major contributors to its overwhelming market growth. Europe, with a 30 per cent share, is the second largest regional market due to proactive government policies to reduce disease-related mortality and increased funding for life science research and development to counteract bacterial antibiotic resistance. Asia Pacific is accounting for 20% of its share due to the increasing burden on primary health care centers associated with infectious diseases and increasing public health awareness.

IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions and Wolters Kluwer N.V.

Key Market Movements:

  • Rising prevalence of infectious disease and antibiotic resistance by bacteria
  • Availability of different configuration solutions making real time infection surveillance successful
  • Increasing number of primary healthcare centers and IT-healthcare market participants worldwide

Access Free Sample Copy of Research Report:

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Product Type

  • Services
  • Software

By Type

  • Urinary Tract Infection
  • Surgical Site Infection
  • Blood Stream Infection
  • Others

By End-Use Type

  • Hospitals
  • Long Term Care Centers
  • Others

By Geography Segment

· North America (the U.S., Rest of North America)

· Europe (U.K., Germany, France, Rest of Europe)

· Asia Pacific (China, Japan, India, Rest of Asia Pacific)

· Rest of the World (the Middle East & Africa, Latin America)

Key questions answered in this report

  • Which are the major IT-healthcare companies providing infection surveillance solutions?
  • What is the global mortality rate associated with hospital acquired infection and antibiotic resistance by bacteria?
  • What is the role of software solution in monitoring infectious disease?
  • What is the disease etiology associated with urinary tract infection?
  • What is the healthcare burden incurred by hospitals related to infectious disease?
  • Why is North America the leading regional segment in infection surveillance solutions market?

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *